Bone marrow mesenchymal stem cells can differentiate and assume corneal keratocyte phenotype

Journal of Cellular and Molecular Medicine

Volumn 16, Issue 5, 2012, Pages 1114-1124

  Liu, Hongshan ^a   Zhang, Jianhua ^a   Liu, Chia Yang ^a   Hayashi, Yasuhito ^a   Kao, Winston W Y ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Bone marrow; Cell therapy; Cornea; Keratocytes; Mesenchymal stem cells

Indexed keywords

KERA PROTEIN, MOUSE; KERATAN SULFATE; LUMICAN; PROTEOCHONDROITIN SULFATE; PROTEOGLYCAN;

ANIMAL; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL MOTION; CHIMERA; CONJUNCTIVA; CORNEA CELL; CORNEA TRANSPLANTATION; CYTOLOGY; GENETICS; GRAFT REJECTION; MALE; MESENCHYMAL STEM CELL; METABOLISM; MOUSE; TRANSGENIC MOUSE; TRANSPLANTATION;

ANIMALS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL MOVEMENT; CHIMERA; CHONDROITIN SULFATE PROTEOGLYCANS; CONJUNCTIVA; CORNEAL KERATOCYTES; CORNEAL TRANSPLANTATION; GRAFT REJECTION; KERATAN SULFATE; MALE; MESENCHYMAL STEM CELLS; MICE; MICE, TRANSGENIC; PROTEOGLYCANS;

MUS; MUS MUSCULUS;

EID: 84860323376     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2011.01418.x     Document Type: Article

References (51)

1. Griffiths IR, Burns N, Crawford AR. Early vascular changes in the spinal grey matter following impact injury. Acta Neuropathol. 1978; 41: 33-9.
2. Gudewicz PW, Frewin MB, Heinel LA, et al. Priming of human monocyte superoxide production and arachidonic acid metabolism by adherence to collagen- and basement membrane-coated surfaces. J Leukoc Biol. 1994; 55: 423-9.
3. Lafrenie RM, Wahl LM, Epstein JS, et al. HIV-1-Tat modulates the function of monocytes and alters their interactions with microvessel endothelial cells. A mechanism of HIV pathogenesis. J Immunol. 1996; 156: 1638-45.
4. Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infarcted myocardium. Nature. 2001; 410: 701-5.
5. Pittenger MF, Martin BJ. Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res. 2004; 95: 9-20.
6. Sutherland FWH, Perry TE, Yu Y, et al. From stem cells to viable autologous semilunar heart valve. Circulation. 2005; 111: 2783-91.
7. Asahara T, Masuda H, Takahashi T, et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res. 1999; 85: 221-8.
8. Rafii S, Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med. 2003; 9: 702-12.
9. Noel D, Djouad F, Jorgense C. Regenerative medicine through mesenchymal stem cells for bone and cartilage repair. Curr Opin Investig Drugs. 2002; 3: 1000-4.
10. Awad HA, Butler DL, Boivin GP, et al. Autologous mesenchymal stem cell-mediated repair of tendon. Tissue Eng. 1999; 5: 267-77.
11. Kataoka K, Medina RJ, Kageyama T, et al. Participation of adult mouse bone marrow cells in reconstitution of skin. Am J Pathol. 2003; 163: 1227-31.
12. Nakagawa H, Akita S, Fukui M, et al. Human mesenchymal stem cells successfully improve skin-substitute wound healing. Br J Dermatol. 2005; 153: 29-36.
13. Szmitko PE, Fedak PWM, Weisel RD, et al. Endothelial progenitor cells new hope for a broken heart. Circulation. 2003; 107: 3093-100.
14. Grant MB, May WS, Caballero S, et al. Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization. Nat Med. 2002; 8: 607-12.
15. Murayama T, Teppera OM, Silvera M, et al. Determination of bone marrow-derived endothelial progenitor cell significance in angiogenic growth factor-induced neovascularization in vivo. Exp Hematol. 2002; 30: 967-72.
16. Orlic D, Kajstura J, Chimenti S, et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci USA. 2001; 98: 10344-9.
17. Fathke C, Wilson L, Hutter J, et al. Contribution of bone marrow-derived cells to skin: collagen deposition and wound repair. Stem Cells. 2004; 22: 812-22.
18. Nygren JM, Jovinge S, Breitbach M, et al. Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat Med. 2004; 10: 494-501.
19. Balsam LB, Wagers AJ, Christensen JL, et al. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature. 2004; 428: 668-73.
20. Popp FC, Eggenhofer E, Renner P, et al. Mesenchymal stem cells can affect solid organ allograft survival. Transplantation. 2009; 87: S57-62.
21. Dai LJ, Li HY, Guan LX, et al. The therapeutic potential of bone marrow-derived mesenchymal stem cells on hepatic cirrhosis. Stem Cell Res. 2009; 2: 16-25.
22. Chhabra P, Brayman KL. The use of stem cells in kidney disease. Curr Opin Organ Transplant. 2009; 14: 72-8.
23. Kitada M, Dezawa M. Induction system of neural and muscle lineage cells from bone marrow stromal cells; a new strategy for tissue reconstruction in degenerative diseases. Histol Histopathol. 2009; 24: 631-42.
24. Lasala GP, Minguell JJ. Bone marrow-derived stem/progenitor cells: their use in clinical studies for the treatment of myocardial infarction. Heart Lung Circ. 2009; 18: 171-80.
25. Horwitz EM, Prockop DJ, Fitzpatrick LA, et al. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med. 1999; 5: 309-13.
26. Urbich C, Dimmeler S. Endothelial progenitor cells: characterization and role in vascular biology. Circ Res. 2004; 95: 343-53.
27. Kawada H, Fujita J, Kinjo K, et al. Nonhematopoietic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction. Blood. 2004; 104: 3581-7.
28. Fernandez M, Simon V, Herrera G, et al. Detection of stromal cells in peripheral blood progenitor cell collections from breast cancer patients. Bone Marrow Transplant. 1997; 20: 265-71.
29. Liu H, Zhang J, Liu CY, et al. Cell therapy of congenital corneal diseases with umbilical mesenchymal stem cells: lumican null mice. PloS One. 2010; 5: e10707. doi: 10.1371/journal.pone.0010707.
30. Weng DY, Zhang Y, Hayashi Y, et al. Promiscuous recombination of LoxP alleles during gametogenesis in cornea Cre driver mice. Molec Vision. 2008; 14: 562-71.
31. Kao WW. Corneal morphogenesis during development and diseases. Eye Contact Lens. 2010; 36: 265-8.
32. Carlson EC, Lin M, Liu C-Y, et al. Keratocan and lumican regulate neutrophil infiltration and corneal clarity in lipopolysacharide-induced keratitis by direct interaction with CXCL1. J Biol Chem. 2007; 282: 35502-9.
33. Eglitis M, Mezey E. Hematopoietic cells differentiate into both microglia and macroglia in the brains of adult mice. Proc Natl Acad Sci USA. 1997; 94: 4080-5.
34. Theise ND, Nimmakayalu M, Gardner R, et al. Liver from bone marrow in humans. Hepatology. 2000; 32: 11-6.
35. Brissette-Storkus CS, Reynolds SM, Lepisto AJ, et al. Identification of a novel macrophage population in the normal mouse corneal stroma. Invest Ophthalmol Vis Sci. 2002; 43: 2264-71.
36. + corneal stromal cells are bone marrow-derived and express hematopoietic stem cell markers. Stem Cells. 2005; 23: 507-15.
37. Deng W, Han Q, Liao L, et al. Engrafted bone marrow-derived flk-(11) mesenchymal stem cells regenerate skin tissue. Tissue Eng. 2005; 11: 110-9.
38. Brittan M, Braun KM, Reynolds LE, et al. Bone marrow cells engraft within the epidermis and proliferate in vivo with no evidence of cell fusion. J Pathol. 2005; 205: 1-13.
39. Vaquero J, Zurita M. Bone marrow stromal cells for spinal cord repair: a challenge for contemporary neurobiology. Histol Histopathol. 2009; 24: 107-16.
40. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999; 284: 143-7.
41. Azizi SA, Stokes D, Augelli BJ, et al. Engraftment and migration of human bone marrow stromal cells implanted in the brains of albino rats-similarities to astrocyte grafts. Proc Natl Acad Sci U S A. 1998; 95: 3908-13.
42. Pereira RF, Halford KW, O'Hara MD, et al. Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice. Proc Natl Acad Sci USA. 1995; 92: 4857-61.
43. Jackson KA, Majka SM, Wang H, et al. Regeneration of ischaemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest. 2001; 107: 1395-402.
44. Mangi AA, Noiseux N, Kong D, et al. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med. 2003; 9: 1195-201.
45. Sato Y, Araki H, Kato J, et al. Human mesenchymal stem cells xenografted directly to rat liver are differentiated into human hepatocytes without fusion. Blood. 2005; 106: 756-63.
46. Horwitz EM, Blanc KL, Dominici M, et al. Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy. 2005; 7: 393-5.
47. Dominici M, Blanc KL, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2005; 7: 393-5.
48. Litvack ML, Palaniyar N. Review: soluble innate immune pattern-recognition proteins for clearing dying cells and cellular components: implications on exacerbating or resolving inflammation. Innate Immun. 2010; 16: 191-200.
49. Milner CM, Higman VA, Day AJ. TSG6: a pluripotent inflammatory mediator?Biochem Soc Trans. 2006; 34: 446-50.
50. Ren G, Zhang L, Zhao X, et al. Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell. 2008; 2: 141-50.
51. Ren G, Su J, Zhang L, et al. Species variation in the mechanisms of mesenchymal stem cell-mediated immunsuppression. Stem Cells. 2009; 27: 1954-62.